CMS ends Biden-era proposal to expand Medicare coverage of anti-obesity drugs. Seniors continue paying out of pocket for ...

This week has been a brutal reminder of how politics and politicians like to work and be seen. How important it is to be the ...

The Centers for Medicare and Medicaid Services said late Friday that it would not cover medications such as Wegovy that are ...

TORONTO - A Canadian researcher has won a 2025 Breakthrough Prize in Life Sciences for discovering the GLP-1 hormone used in ...

Expanding obesity treatment access could generate $10 trillion for the country by boosting productivity, cutting healthcare ...

President Donald Trump's administration has decided not to cover expensive, high-demand obesity treatments under the federal ...

The Centres for Medicare and Medicaid Services on Friday said that it did not move forward with a proposal put forward by the ...

President Donald Trump’s team is rejecting former President Biden's plan to cover weight loss drugs like Wegovy and Zepbound for older Americans through Medicare. The Centers for Medicare and Medicaid ...

The Centers for Medicare & Medicaid Services said on Friday it did not move forward with a proposal put forth by the Biden ...

Obesity rates in France have doubled since the late 1990s, affecting around 10 million people. Behind those numbers are lives shaped not just by health concerns, but by judgment, exclusion, and ...

Five researchers have been jointly awarded one of this year's Breakthrough Prizes in Life Sciences for their contributions to the development of Ozempic-style drugs.

In a recent decision, the Centers for Medicare and Medicaid Services have declined a proposal to expand Medicare coverage for ...